https://scholars.lib.ntu.edu.tw/handle/123456789/637314
Title: | Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: A phase 2 proof-of-concept trial | Authors: | LI-MIN HUANG Schibler, Andreas Huang, Yi-Chuan Tai, Andrew Chi, Hsin Chieng, Chae-Hee Wang, Jinn-Li Goldbart, Aviv Tang, Swee-Ping Huang, Yhu-Chering George, Shane Alabaz, Derya Bentur, Lea Su, Siew-Choo de Bruyne, Jessie Karadag, Bulent Gu, Feng Zou, Gang Toovey, Stephen DeVincenzo, John P Wu, Jim Z |
Keywords: | AK0529; fusion inhibitor; infants; respiratory syncytial virus (RSV); ziresovir | Issue Date: | Jul-2023 | Journal Volume: | 17 | Journal Issue: | 7 | Source: | Influenza and other respiratory viruses | Abstract: | Respiratory syncytial virus (RSV) infection is a cause of substantial morbidity and mortality in young children. There is currently no effective therapy available. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/637314 | ISSN: | 17502640 | DOI: | 10.1111/irv.13176 |
Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.